Evofem Biosciences (EVFM) Revenue (2020 - 2026)
Evofem Biosciences (EVFM) reported Revenue of $2.63 million for Q2 2026, down 45.4% from $4.83 million a year earlier but up 192.9% from the prior quarter.
Powered by 
Analysis
Evofem Biosciences (EVFM) Revenue (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Evofem Biosciences' Revenue came in at $18.05 million, up 4.5% year-over-year; for FY2025, it came in at $20.18 million, up 4.2% from FY2024.
- Revenue has increased for four consecutive years, with a five-year compound annual growth rate of 114.4% (FY2020 to FY2025).
- By year, Revenue came in at $19.36 million in FY2024 (+6.3%), $18.22 million in FY2023 (+8.2%), $16.84 million in FY2022 (+104.2%) and $8.24 million in FY2021.
- Five-year quarterly Revenue spans a low of $181,000 in Q4 2022 and a high of $9.56 million in Q4 2025.
- Year over year, Revenue gained in five of the last eight quarters, with an average decline of 2.5%.
- The high point for year-over-year Revenue in five years was Q3 2021 (growth of 515.8%); the low point was Q4 2022 (a decline of 94.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $899,000 (Q1 2026), $9.56 million (Q4 2025) and $4.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Evofem Biosciences | 824,026.65 | 824,026.65 | 2.12 Mn | 2.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.63 Mn |
| Mar 31, 2026 | 899,000.00 |
| Dec 31, 2025 | 9.56 Mn |
| Sep 30, 2025 | 4.95 Mn |
| Jun 30, 2025 | 4.83 Mn |
| Mar 31, 2025 | 845,000.00 |
| Dec 31, 2024 | 7.10 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | 4.16 Mn |
| Mar 31, 2024 | 3.60 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 5.11 Mn |
| Jun 30, 2023 | 2.46 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | 181,000.00 |
| Sep 30, 2022 | 6.37 Mn |
| Jun 30, 2022 | 6.03 Mn |
| Mar 31, 2022 | 4.25 Mn |
| Dec 31, 2021 | 3.57 Mn |
| Sep 30, 2021 | 1.71 Mn |
API Access
Evofem Biosciences Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=EVFM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();